Androgens and estrogens in benign prostatic hyperplasia: Past, present and future
Top Cited Papers
- 26 May 2011
- journal article
- review article
- Published by Elsevier in Differentiation
- Vol. 82 (4-5), 184-199
- https://doi.org/10.1016/j.diff.2011.04.006
Abstract
No abstract availableKeywords
This publication has 202 references indexed in Scilit:
- Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate CancerJournal of Urology, 2010
- Serum bisphenol A pharmacokinetics and prostate neoplastic responses following oral and subcutaneous exposures in neonatal Sprague–Dawley ratsReproductive Toxicology, 2010
- The pros and cons of phytoestrogensFrontiers in Neuroendocrinology, 2010
- DHEA metabolism in prostate: For better or worse?Molecular and Cellular Endocrinology, 2009
- Urothelial transdifferentiation to prostate epithelia is mediated by paracrine TGF-β signalingDifferentiation, 2008
- Keratinocyte‐derived chemokine induces prostate epithelial hyperplasia and reactive stroma in a novel transgenic mouse modelThe Prostate, 2008
- Nonhuman primates as models for studies of prostate specific antigen and prostatic diseasesThe Prostate, 2008
- The role of estrogens and estrogen receptors in normal prostate growth and diseaseSteroids, 2007
- Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptorProceedings of the National Academy of Sciences, 2007
- Role of the stromal microenvironment in carcinogenesis of the prostateInternational Journal of Cancer, 2003